Benefits of a self-management program in low-income African-American women with systemic lupus erythematosus: results of a pilot test

Abstract

Minorities with systemic lupus erythematosus (SLE) are at high risk of poor disease outcomes and may face challenges in effectively self-managing multiple health problems. The Chronic Disease Self-Management Program (CDSMP) is an evidence-based intervention that improves the health of people with chronic illnesses. Although the CDSMP is offered by organizations throughout the United States and many countries around the world, it has not been tested among SLE patients. We pilot tested the benefits of the CDSMP in low-income African American patients with SLE. CDSMP workshops were delivered to 49 African American women with SLE who received medical care at a public lupus clinic in Atlanta, Georgia, US. We compared pre-post CDSMP changes (from baseline to 4 months after the start of the intervention) in health status, self-efficacy and self-management behaviors using self-reported measures. Additionally, we assessed health care utilization changes using electronic administrative records in the 6-month periods before and after the intervention. We observed significant improvements post-intervention in the SF-36 physical health component summary (mean change = 2.4, p = 0.032); self-efficacy (mean change = 0.5, p = 0.035); and several self-management behaviors: cognitive symptoms management (mean change = 0.3, p = 0.036); communication with physicians (mean change = 0.4, p = 0.01); and treatment adherence (mean change = 0.4, p = 0.01). The median number of outpatient visits decreased from 3 to 1 (p < .0001). The CDSMP is a promising intervention for low-income African Americans with SLE. It is an inexpensive program with growing availability around the world that should be further evaluated as a resource to improve patient-centered outcomes and decrease health service utilization among SLE patients.

Keywords

SLE Self-management Low SES Racial minorities

Get full access to this article

View all access options for this article.

References

Alarcon

McGwin

G, Jr

Bartolucci

. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001; 44: 2797–2806.

Cooper

Treadwell

St Clair

Gilkeson

Dooley

. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 993–999.

Alarcon

McGwin

G, Jr

Uribe

. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 2004; 51: 465–474.

Rhew

Manzi

Dyer

. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res 2009; 153: 51–59.

Liang

Partridge

Daltroy

Straaton

Galper

Holman

. Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum 1991; 34: 1187–1196.

Pons-Estel

Gonzalez

Zhang

. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology 2009; 48: 817–822.

Goldman

Smith

. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A 2002; 99: 10929–10934.

Adams

KGA

Corrigan

. Committee on the Crossing the Quality Chasm: Next Steps Toward a New Health Care System. 1st Annual Crossing the Quality Chasm Summit: A Focus on Communities , Washington DC: National Academies Press, 2004.

Brady

Jernick

Hootman

Sniezek

. Public health interventions for arthritis: expanding the toolbox of evidence-based interventions. J Womens Health (Larchmt) 2009; 18: 1905–1917.

10.

Sapag JC, Lange I, Campos S and Piette JD. Innovative care and self-care strategies for people with chronic diseases in Latin America. Rev Panam Salud Publica 2010; 27: 1--9.

11.

van Eijk-Hustings

van Tubergen

Bostrom

. EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Ann Rheum Dis 2012; 71: 13–19.

12.

UK Department of Health. Self care—a real choice: self care support—a practical option. In: Health Do (ed.) 2005. Available at http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4100717. Accessed July 2012.

13.

Braden

McGlone

Depka

. Systemic lupus erythematosus (SLE) self- help course, leaders manual , Atlanta, GA: Arthritis Foundation, 1987.

14.

Braden

. Patterns of change over time in learned response to chronic illness among participants in a systemic lupus erythematosus self-help course. Arthritis Care Res 1991; 4: 158–167.

15.

Lorig

Ritter

Stewart

. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care 2001; 39: 1217–1223.

16.

Lorig

Sobel

Ritter

Laurent

Hobbs

. Effect of a self-management program on patients with chronic disease. Eff Clin Pract 2001; 4: 256–262.

17.

Goeppinger

Armstrong

Schwartz

Ensley

Brady

. Self-management education for persons with arthritis: managing comorbidity and eliminating health disparities. Arthritis Rheum 2007; 57: 1081–1088.

18.

Chan

Hui

Chan

. Evaluation of chronic disease self-management programme (CDSMP) for older adults in Hong Kong. J Nutr Health Aging 2011; 15: 209–214.

19.

Swerissen

Belfrage

Weeks

. A randomised control trial of a self-management program for people with a chronic illness from Vietnamese, Chinese, Italian and Greek backgrounds. Patient Educ Couns 2006; 64: 360–368.

20.

Reeves

Kennedy

Fullwood

. Predicting who will benefit from an Expert Patients Programme self-management course. Br J Gen Pract 2008; 58: 198–203.

21.

Smeulders

van Haastregt

Ambergen

. Heart failure patients with a lower educational level and better cognitive status benefit most from a self-management group programme. Patient Educ Couns 2010; 81: 214–221.

22.

Ware

JE, Jr

Sherbourne

. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.

23.

Radloff

. The CES-D Scale: a self-report depression measure for research in the general population. Appl Psychol Meas 1977; 1: 385–401.

24.

Centers for Disease Control and Prevention. Sorting Through the Evidence for the Arthritis Self-Management Program and the Chronic Disease Self-Management Program. Executive Summary of ASMP/CDSMP Meta-Analyses 2011. Available at: http://www.cdc.gov/arthritis/docs/ASMP-executive-summary.pdf. Accessed July 2012.

25.

Lorig

KSA

Ritter

Gonzalez

Laurent

Lynch

. Outcome Measures for Health Education and other Health Care Interventions , Thousand Oaks, CA: Sage Publications, 1996.

26.

Morisky

Green

Levine

. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1): 67–74.

27.

Lorig

Sobel

Stewart

. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care 1999; 37: 5–14.

28.

Bandura

. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84: 191–215.

29.

Norman

Sloan

Wyrwich

. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582–592.

30.

Rose

Arenson

Harrod

Salkey

Santana

Diamond

. Evaluation of the Chronic Disease Self-Management Program with low-income, urban, African American older adults. J Community Health Nurs 2008; 25: 193–202.

31.

Farivar

Liu

Hays

. Half standard deviation estimate of the minimally important difference in HRQOL scores? Expert Rev Pharmacoecon Outcomes Res 2004; 4: 515–523.

32.

Kuriya

Gladman

Ibanez

Urowitz

. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 2008; 59: 181–185.

33.

Stanford Patient Education Research Center Web site. Available at: http://patienteducation.stanford.edu/programs/cdsmp.html. Accessed July 2012.